Infliximab as the First Retreatment in Patients with Kawasaki Disease Resistant to Initial Intravenous Immunoglobulin
- 등재 SCIE, SCOPUS
- 발행기관 Lippincott Williams and Wilkins
- 발행년도 2015
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000122815
- 본문언어 영어
- Published As http://dx.doi.org/10.1097/INF.0000000000001039
- 저작권 이화여자대학교 논문은 저작권에 의해 보호받습니다.
초록/요약
Forty-three patients with Kawasaki disease (KD) who were resistant to initial intravenous immunoglobulin (IVIG) were randomized to receive either a second dose of IVIG (n=32) or infliximab (n=11). With IVIG retreatment 21 patients (65.6%) responded, and with infliximab 10 patients (90.9%) responded. The infliximab group had shorter duration of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
more